FDA faces regulatory challenges with new approaches to medicine
The Food and Drug Administration (FDA) faces unprecedented regulatory challenges not just with new products but with entirely new fields of activity that are likely to transform medicine in the decades...
View ArticleMultisystem failure: the story of anti-influenza drugs
Last year the Cochrane team, with the help of The BMJ’s open data campaign, finally got access to full clinical study reports on neuraminidase inhibitors. Tom Jefferson and Peter Doshi explain what the...
View ArticleThe slow death of lethal injection
The medicalization of execution was once seen as the solution to death penalty concerns. Instead it has only spawned new legal challenges, says Owen Dyer, and a tightening drugs embargo that now...
View Article
More Pages to Explore .....
